Many other RTKs are known to play a role in lung adenocarcinoma, including ALK and ERBB2, and it is interesting to speculate that DOK2 may also inhibit lung tumorigenesis driven by those oncogenes. The gene discussed is DOK2; the disease is lung adenocarcinoma.